Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma <i>in vivo</i>.

Significant findings (*) with a p -value <0.05 and highly significant findings (**) with a p -value <0.01 or (***) with a p -value <0.001.

also in 132,142 other papers